The #1 Breakthrough Biotech Stock for 2023
CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!
Posted by Amber Lancaster | Nov 1, 2022 | Investment Opportunities, Technology, Trending, Winning Investor Daily
CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!
Posted by Joseph Hargett | Oct 12, 2022 | Great Stuff
Meta’s Mixed Reality Mark had them metaverse memes (memes). VR goggles with the fur (with the...
Read MorePosted by Joseph Hargett | Oct 4, 2022 | Great Stuff
Crude Intentions Great Ones, we’re talking oil again today. You know, black gold? Texas tea?...
Read MorePosted by Joseph Hargett | Sep 28, 2022 | Great Stuff
Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: BIIB). Today, I...
Read MorePosted by Joseph Hargett | Sep 22, 2022 | Great Stuff
Robinhood’s Even Flow Freeeeezin’ … something something something … made of concrete… OK, don’t...
Read MoreSubscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Financial Analyst
James Hickman (aka Simon Black) is an international investor, entrepreneur, [...]
Research Analyst
Chief Investment Strategist of Money & Markets
Founder, Agora
Director of VIP Services
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”
- Larry K.
"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"
- Keith S.